{
    "code": "56031764",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56031764",
    "time": "2023-10-19 20:48:12",
    "許可證字號": "衛部醫器輸字第031764號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD11899",
    "有效日期": "117\/10\/29",
    "發證\/登錄日期": "107\/10\/29",
    "許可證\/登錄種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05603176404",
    "中文品名": "希摩西爾液態抗活化第十因子試驗組",
    "英文品名": "HemosIL Liquid Anti-Xa",
    "效能": "本產品供利用IL凝集系統(ACL TOP Family及 ELITE PRO)搭配HemosIL肝素校正液(HemosIL Heparin Calibrators)，對檸檬酸鹽處理後人類血漿內傳統肝素(UFH)及低分子量肝素(LMWH)活性進行定量之自動顯色試驗。\r\n本產品亦供利用ACL TOP Family系統搭配HemosIL Rivaroxaban校正液(供Rivaroxaban試驗使用)及HemosIL Apixaban校正液(供Apixaban試驗使用)，測量檸檬酸鹽處理後人類血漿內第Xa因子直接抑制劑(例如:Rivaroxaban、Apixaban)之濃度。",
    "醫器規格": "0020302601，以下空白。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "B血液學及病理學裝置",
    "醫器次類別一": "B7525肝素分析",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "台灣沃芬有限公司",
    "申請商地址": "臺北市內湖區堤頂大道二段501號4樓",
    "主製造廠": [
        {
            "製造廠名稱": "INSTRUMENTATION LABORATORY CO.",
            "製造廠廠址": "180 HARTWELL RD. BEDFORD, MA 01730-2443 USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560317640001-107-12-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56031764&Seq=001&Type=9"
        },
        {
            "title": "560317640002-107-12-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56031764&Seq=001&Type=8"
        }
    ]
}